UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 123

Sortiert nach

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer

International journal of radiation oncology, biology, physics, 2016-05, Vol.95 (1), p.422-434

2016

Volltextzugriff (PDF)

Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy

Cancers, 2022-06, Vol.14 (12), p.3005

2022

Volltextzugriff (PDF)

Metabolic management of microenvironment acidity in glioblastoma

Frontiers in oncology, 2022-08, Vol.12, p.968351-968351

2022

Volltextzugriff (PDF)

NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma

Clinical cancer research, 2016-06, Vol.22 (12), p.3105-3117

2016

Volltextzugriff (PDF)

Unbiased Compound Screening Identifies Unexpected Drug Sensitivities and Novel Treatment Options for Gastrointestinal Stromal Tumors

Cancer research (Chicago, Ill.), 2014-02, Vol.74 (4), p.1200-1213

2014

Volltextzugriff (PDF)

Minimally Invasive Preclinical Monitoring of the Peritoneal Cavity Tumor Microenvironment

Cancers, 2022-03, Vol.14 (7), p.1775

2022

Volltextzugriff (PDF)

The folate cycle is a new metabolic weakness of cancer

Molecular & cellular oncology, 2017-11, Vol.4 (6), p.e1327004

2017

Volltextzugriff (PDF)

Effect of Ketogenic Diets on Cardio-Metabolic Outcomes in Cancer Patients: A Systematic Review and Meta-Analysis of Controlled Clinical Trials

Nutrition and cancer, 2023, Vol.75 (1), p.95-111

2023

Volltextzugriff (PDF)

Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition

Journal of neuro-oncology, 2017-05, Vol.132 (3), p.393-400

2017

Volltextzugriff (PDF)

Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways

Neuro-oncology (Charlottesville, Va.), 2013-05, Vol.15 (5), p.562-577

2013

Volltextzugriff (PDF)

Endoplasmic reticulum chaperone prolyl 4-hydroxylase, beta polypeptide (P4HB) promotes malignant phenotypes in glioma via MAPK signaling

Oncotarget, 2017-09, Vol.8 (42), p.71911-71923

2017

Volltextzugriff (PDF)

IDH1 mutation-associated long non-coding RNA expression profile changes in glioma

Journal of neuro-oncology, 2015-11, Vol.125 (2), p.253-263

2015

Volltextzugriff (PDF)

Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer

Oncogenesis (New York, NY), 2018-05, Vol.7 (5), p.44-12, Article 44

2018

Volltextzugriff (PDF)

Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response

Anticancer research, 2014-06, Vol.34 (6), p.2957-2966

2014

Volltextzugriff (PDF)

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide

Journal of neuro-oncology, 2012-09, Vol.109 (3), p.467-475

2012

Volltextzugriff (PDF)

MicroRNA-210 and Endoplasmic Reticulum Chaperones in the Regulation of Chemoresistance in Glioblastoma

Journal of Cancer, 2015-01, Vol.6 (3), p.227-232

2015

Volltextzugriff (PDF)

Stomal seeding of head and neck cancer by percutaneous endoscopic gastrostomy tube placement

Annals of surgical oncology, 1995-03, Vol.2 (2), p.170-173

1995

Volltextzugriff (PDF)

NK cell-based cancer immunotherapy: from basic biology to clinical development

Journal of hematology and oncology, 2021-01, Vol.14 (1), p.7-17, Article 7

2021

Volltextzugriff (PDF)

Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma

PLoS genetics, 2017-05, Vol.13 (5), p.e1006787-e1006787

2017

Volltextzugriff (PDF)

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

Journal of clinical oncology, 2016-08, Vol.34 (24), p.2925-2934

2016

Volltextzugriff (PDF)

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

Journal of clinical oncology, 2015-08, Vol.33 (23), p.2563-2577

2015

Volltextzugriff (PDF)

Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review

PloS one, 2017-06, Vol.12 (6), p.e0179733-e0179733

2017

Volltextzugriff (PDF)

Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis

Cancer, 2021-07, Vol.127 (14), p.2409-2422

2021

Volltextzugriff (PDF)

Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer

Journal of clinical oncology, 2023-01, Vol.41 (3), p.485-496

2023

Volltextzugriff (PDF)

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Clinical cancer research, 2008-07, Vol.14 (13), p.4275-4283

2008

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(123)

Sprache

Englisch
(123)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer

Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy

Metabolic management of microenvironment acidity in glioblastoma

NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma

Unbiased Compound Screening Identifies Unexpected Drug Sensitivities and Novel Treatment Options for Gastrointestinal Stromal Tumors

Minimally Invasive Preclinical Monitoring of the Peritoneal Cavity Tumor Microenvironment

The folate cycle is a new metabolic weakness of cancer

Effect of Ketogenic Diets on Cardio-Metabolic Outcomes in Cancer Patients: A Systematic Review and Meta-Analysis of Controlled Clinical Trials

Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition

Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways

Endoplasmic reticulum chaperone prolyl 4-hydroxylase, beta polypeptide (P4HB) promotes malignant phenotypes in glioma via MAPK signaling

IDH1 mutation-associated long non-coding RNA expression profile changes in glioma

Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer

Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide

MicroRNA-210 and Endoplasmic Reticulum Chaperones in the Regulation of Chemoresistance in Glioblastoma

Stomal seeding of head and neck cancer by percutaneous endoscopic gastrostomy tube placement

NK cell-based cancer immunotherapy: from basic biology to clinical development

Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review

Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis

Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Aktive Filter

Suchergebnisse filtern